Real-world Study of Dedifferentiated Liposarcoma Patients in China

Status Completed

Clinical Trial Summary

This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06115681
Study type	Observational
Source	Boehringer Ingelheim
Contact
Status	Completed
Phase
Start date	March 13, 2024
Completion date	May 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03307616` - Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery	Phase 2
Completed	`NCT01913652` - Ph II Cabazitaxel DD Liposarcoma	Phase 2
Not yet recruiting	`NCT06389799` - A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)	Phase 2
Recruiting	`NCT05886634` - A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma	Phase 2
Active, not recruiting	`NCT02846987` - Study of Abemaciclib in Dedifferentiated Liposarcoma	Phase 2
Terminated	`NCT04979442` - Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma	Phase 3
Completed	`NCT02606461` - Selinexor in Advanced Liposarcoma	Phase 2/Phase 3
Active, not recruiting	`NCT04242238` - Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas	Phase 1
Withdrawn	`NCT00969917` - Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma	Phase 2
Active, not recruiting	`NCT03651375` - Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	Phase 2
Terminated	`NCT03604783` - Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors	Phase 1
Not yet recruiting	`NCT05496569` - TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma	Phase 2